{"title":"[原发性骨髓淋巴瘤患者的临床特征和预后】。]","authors":"Qiao-Lin Chen, You-Fan Feng, Yuan Fu, Fei Liu, Wen-Jie Zhang, Yang Chen, Xiao-Fang Wei, Qi-Ke Zhang","doi":"10.19746/j.cnki.issn.1009-2137.2024.04.022","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical characteristics and prognosis of primary bone marrow lymphoma.</p><p><strong>Methods: </strong>The clinical data of 6 patients with primary bone marrow lymphoma admitted to Gansu Provincial People's Hospital from February 2011 to March 2023 were collected, and their clinical characteristics and prognosis were retrospectively analyzed and summarized.</p><p><strong>Results: </strong>The median age of 6 patients was 61(52-74) years old. There were 2 males and 4 females. All patients had fever and abnormal blood routine examination. Physical examination and imaging examination showed no lymphadenopathy, no extranodal lesions in lung, gastrointestinal, liver and spleen, skin, etc. After strict exclusion of systemic lymphoma involvement in the bone marrow, the diagnosis was confirmed by bone marrow examination, 5 cases were primary myeloid diffuse large B-cell lymphoma and 1 case was primary myeloid peripheral T-cell lymphoma (NOS). 1 case abandoned treatment, 5 cases received CHOP-like or combined R regimen, including 1 case of autologous stem cell transplantation. 4 cases died and 2 case survived. The median OS was 5.5 (1-36) months.</p><p><strong>Conclusion: </strong>The prognosis of primary marrow lymphoma is poor, and bone marrow-related examination is an important means of diagnosis. Diffuse large B-cell lymphoma is the most common histomorphologic and immune subtype, and autologous hematopoietic stem cell transplantation may improve the prognosis.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":"32 4","pages":"1117-1120"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical Characteristics and Prognosis of Patients with Primary Bone Marrow Lymphoma].\",\"authors\":\"Qiao-Lin Chen, You-Fan Feng, Yuan Fu, Fei Liu, Wen-Jie Zhang, Yang Chen, Xiao-Fang Wei, Qi-Ke Zhang\",\"doi\":\"10.19746/j.cnki.issn.1009-2137.2024.04.022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To investigate the clinical characteristics and prognosis of primary bone marrow lymphoma.</p><p><strong>Methods: </strong>The clinical data of 6 patients with primary bone marrow lymphoma admitted to Gansu Provincial People's Hospital from February 2011 to March 2023 were collected, and their clinical characteristics and prognosis were retrospectively analyzed and summarized.</p><p><strong>Results: </strong>The median age of 6 patients was 61(52-74) years old. There were 2 males and 4 females. All patients had fever and abnormal blood routine examination. Physical examination and imaging examination showed no lymphadenopathy, no extranodal lesions in lung, gastrointestinal, liver and spleen, skin, etc. After strict exclusion of systemic lymphoma involvement in the bone marrow, the diagnosis was confirmed by bone marrow examination, 5 cases were primary myeloid diffuse large B-cell lymphoma and 1 case was primary myeloid peripheral T-cell lymphoma (NOS). 1 case abandoned treatment, 5 cases received CHOP-like or combined R regimen, including 1 case of autologous stem cell transplantation. 4 cases died and 2 case survived. The median OS was 5.5 (1-36) months.</p><p><strong>Conclusion: </strong>The prognosis of primary marrow lymphoma is poor, and bone marrow-related examination is an important means of diagnosis. Diffuse large B-cell lymphoma is the most common histomorphologic and immune subtype, and autologous hematopoietic stem cell transplantation may improve the prognosis.</p>\",\"PeriodicalId\":35777,\"journal\":{\"name\":\"中国实验血液学杂志\",\"volume\":\"32 4\",\"pages\":\"1117-1120\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国实验血液学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨原发性骨髓淋巴瘤的临床特征和预后:研究原发性骨髓淋巴瘤的临床特点及预后:收集2011年2月至2023年3月甘肃省人民医院收治的6例原发性骨髓淋巴瘤患者的临床资料,对其临床特征和预后进行回顾性分析和总结:结果:6名患者的中位年龄为61(52-74)岁。结果:6 名患者的中位年龄为 61(52-74)岁,其中 2 名男性,4 名女性。所有患者均有发热和血常规检查异常。体格检查和影像学检查显示无淋巴结肿大,肺、胃肠、肝脾、皮肤等部位无结节外病变。在严格排除骨髓受累的全身淋巴瘤后,经骨髓检查确诊,5 例为原发性髓系弥漫大 B 细胞淋巴瘤,1 例为原发性髓系外周 T 细胞淋巴瘤(NOS)。1 例放弃治疗,5 例接受了类似 CHOP 或联合 R 方案治疗,其中 1 例接受了自体干细胞移植。4例死亡,2例存活。中位生存期为5.5(1-36)个月:结论:原发性骨髓淋巴瘤的预后较差,骨髓相关检查是诊断的重要手段。弥漫大B细胞淋巴瘤是最常见的组织形态学和免疫亚型,自体造血干细胞移植可改善预后。
[Clinical Characteristics and Prognosis of Patients with Primary Bone Marrow Lymphoma].
Objective: To investigate the clinical characteristics and prognosis of primary bone marrow lymphoma.
Methods: The clinical data of 6 patients with primary bone marrow lymphoma admitted to Gansu Provincial People's Hospital from February 2011 to March 2023 were collected, and their clinical characteristics and prognosis were retrospectively analyzed and summarized.
Results: The median age of 6 patients was 61(52-74) years old. There were 2 males and 4 females. All patients had fever and abnormal blood routine examination. Physical examination and imaging examination showed no lymphadenopathy, no extranodal lesions in lung, gastrointestinal, liver and spleen, skin, etc. After strict exclusion of systemic lymphoma involvement in the bone marrow, the diagnosis was confirmed by bone marrow examination, 5 cases were primary myeloid diffuse large B-cell lymphoma and 1 case was primary myeloid peripheral T-cell lymphoma (NOS). 1 case abandoned treatment, 5 cases received CHOP-like or combined R regimen, including 1 case of autologous stem cell transplantation. 4 cases died and 2 case survived. The median OS was 5.5 (1-36) months.
Conclusion: The prognosis of primary marrow lymphoma is poor, and bone marrow-related examination is an important means of diagnosis. Diffuse large B-cell lymphoma is the most common histomorphologic and immune subtype, and autologous hematopoietic stem cell transplantation may improve the prognosis.